Equities

Simcere Pharmaceutical Group Ltd

Simcere Pharmaceutical Group Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (HKD)6.61
  • Today's Change-0.17 / -2.51%
  • Shares traded3.31m
  • 1 Year change-12.22%
  • Beta0.4365
Data delayed at least 15 minutes, as of Nov 22 2024 08:08 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue6,6086,3245,000
OPERATING EXPENSES
Cost of revenue total1,6241,3271,080
Selling, general and admin. expenses, total2,8552,8352,419
Depreciation/amortization------
Unusual expense(income)(759)11(402)
Other operating expenses, total(151)(382)(150)
Total operating expense5,8965,4633,551
Operating income7128611,449
Other, net------
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes7408861,402
Provision for income taxes26(40)(97)
Net income after taxes7149271,499
Minority interest0.814.148.18
Net income before extra. Items7159311,507
Total extraordinary items------
Net income7159311,507
Inc.avail. to common excl. extra. Items7159311,507
Inc.avail. to common incl. extra. Items7159311,507
EPS RECONCILIATION
Basic/primary weighted average shares2,6092,6112,609
Basic/primary eps excl. extra items0.270.360.58
Basic/primary eps incl. extra items0.270.360.58
Dilution adjustment------
Diluted weighted average shares2,6092,6202,611
Diluted eps excl. extra items0.270.360.58
Diluted eps incl. extra items0.270.360.58
COMMON STOCK DIVIDENDS
DPS - common stock primary issue0.160.160.14
Gross dividend - common stock413419394
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental353471
SUPPLEMENTAL INCOME
Depreciation, supplemental292269234
Total special items(759)11(402)
NORMALISED INCOME
Normalized income before taxes(19)8971,000
Effect of special items on income taxes(266)3.70(141)
Income tax excluding impact of special items(240)(37)(238)
Normalized income after tax2219341,238
Normalized income avail. to common2219381,246
Basic normalized EPS0.080.360.48
Diluted normalized EPS0.080.360.48
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.